Abstract

In this study, emulsion electrospraying assisted by pressurized gas (EAPG) has been performed for the first time to entrap ca. 760 nm droplets of the bioactive eicosapentaenoic acid (EPA)-rich oil into whey protein concentrate (WPC) at room temperature. The submicron droplets of EPA oil were encapsulated within WPC spherical microparticles, with sizes around 5 µm. The EPA oil did not oxidize in the course of the encapsulation performed at 25 °C and in the presence of air, as corroborated by the peroxide value measurements. Attenuated Total Reflection—Fourier Transform Infrared spectroscopy and oxygen consumption tests confirmed that the encapsulated EPA-rich oil showed increased oxidative stability in comparison with the free oil during an accelerated oxidation test under ultraviolet light. Moreover, the encapsulated EPA-rich oil showed increased thermal stability in comparison with the free oil, as measured by oxidative thermogravimetric analysis. The encapsulated EPA-rich oil showed a somewhat reduced organoleptic impact in contrast with the neat EPA oil using rehydrated powdered milk as a reference. Finally, the oxidative stability by thermogravimetric analysis and organoleptic impact of mixtures of EPA and docosahexaenoic acid (DHA)-loaded microparticles was also studied, suggesting an overall reduced organoleptic impact compared to pure EPA. The results here suggest that it is possible to encapsulate 80% polyunsaturated fatty acids (PUFAs)-enriched oils by emulsion EAPG technology at room temperature, which could be used to produce personalized nutraceuticals or pharmaceuticals alone or in combination with other microparticles encapsulating different PUFAs to obtain different targeted health and organoleptic benefits.

Highlights

  • Understanding the relationship between nutrition and health has resulted in the development of new products; most of them aimed at preventing nutrition-related diseases and improve physical and mental well-being [1]

  • The main objective of the present study is to investigate the submicron encapsulation of an eicosapentaenoic acid (EPA)-rich oil via electrospraying assisted by pressurized gas (EAPG) technology to produce EPA encapsulates, which could be used in personalized nutrition alone or in combination with other docosahexaenoic acid (DHA) encapsulates

  • The aim of this research was to study the encapsulation of nanodroplets of EPA-rich oil into whey protein concentrate (WPC) microparticles via the emulsion EAPG process

Read more

Summary

Introduction

Understanding the relationship between nutrition and health has resulted in the development of new products; most of them aimed at preventing nutrition-related diseases and improve physical and mental well-being [1]. Polyunsaturated fatty acids (PUFAs) are one of the most studied compounds in healthcare, according to the Global Organization for EPA and DHA Omega-3 (GOED Omega-3) [2]. There are more than 36,000 published studies on PUFAs, including more than 4000 human clinical trials. Numerous investigations have demonstrated that PUFAs are fundamental for growth and development as well as due to their positive effects on behavior and on the health of the brain, eyes, heart, joints, and skin [3]. There is a great interest from the industry in incorporating PUFAs into the active ingredient market. The PUFAs market is based, especially on alpha-linolenic acid (ALA) C18:3, eicosapentaenoic acid (EPA) C20:5, and docosahexaenoic

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call